Humira costs approximately $3,100 per month, like the TNFα inhibitor etanercept. From 2012 to US patent expiry in 2016, Humira led the list of top-selling pharmaceutical products, and in 2016, it had $16 billion of global sales. Also in 2014, in India, the first adalimumab biosimilar came to market at a price of $200.